Telomerase activation by histone deacetylase inhibitor in normal cells.
about
Human telomerase and its regulationIdentification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complexNFX1 interacts with mSin3A/histone deacetylase to repress hTERT transcription in keratinocytesHistone deacetylase 8 safeguards the human ever-shorter telomeres 1B (hEST1B) protein from ubiquitin-mediated degradationThe proximal promoter region of mTert is sufficient to regulate telomerase activity in ES cells and transgenic animalsCancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical ImplicationsTranscription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) GeneMolecular regulation of telomerase activity in agingTelomerase Activation in Hematological MalignanciesTranscriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cellsSp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cellsRole of histone acetylation in the stimulatory effect of valproic acid on vascular endothelial tissue-type plasminogen activator expressionNatural and pharmacological regulation of telomeraseLysine-specific demethylase 1 (LSD1) Is required for the transcriptional repression of the telomerase reverse transcriptase (hTERT) gene.Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell linesRegulation of the human telomerase reverse transcriptase gene.Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathwayHigh-mobility group A2 protein modulates hTERT transcription to promote tumorigenesis.Telomere and telomerase as targets for anti-cancer and regeneration therapies.Human Telomerase Reverse Transcriptase (hTERT) Transcription Requires Sp1/Sp3 Binding to the Promoter and a Permissive Chromatin Environment.Regulation of telomerase activity by interferon regulatory factors 4 and 8 in immune cells.An unbiased in vivo screen reveals multiple transcription factors that control HPV E6-regulated hTERT in keratinocytes.Epigenetic regulation of the human telomerase reverse transciptase gene: A potential therapeutic target for the treatment of leukemia (Review).Telomerase and telomere length in pulmonary fibrosis.Activation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas.Targeting telomerase in hematologic malignancy.Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene.The tumor suppressor role of CTCF.Human telomerase expression regulation.Human telomerase inhibitors from microbial source.Genetic and epigenetic trends in telomere research: a novel way in immunoepigenetics.Dual roles of c-Myc in the regulation of hTERT gene.Evidence for a relief of repression mechanism for activation of the human telomerase reverse transcriptase promoter.Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines.Early growth response-1 mediates downregulation of telomerase in cervical cancer.Histone deacetylation is directly involved in desilencing the expression of the catalytic subunit of telomerase in normal lung fibroblast.Differential Regulation of Telomerase Reverse Transcriptase Promoter Activation and Protein Degradation by Histone Deacetylase Inhibition.Involvement of histone acetylation in ovarian steroid-induced decidualization of human endometrial stromal cells.
P2860
Q24533247-F796ED02-6CA0-4598-B20D-913724A86476Q24561609-DD44B8EA-2B1D-4637-A4FB-3908D55C6AA1Q24650992-A9C4A437-0F4F-4B44-B947-1E130A854623Q24671304-8ED67ACF-96CD-4D50-B6D1-54EF37277AC6Q25255976-FE371071-70F7-422A-B16B-3A6DD6F2C50CQ26738705-BA5851C9-9C87-42B7-8B37-F54267E1270BQ26739925-31461E07-B137-4AA1-AFAE-D397E4C45DB2Q26861714-3E85FCD0-5618-4536-B373-3C8E450667D9Q28068238-3FC66689-488D-4DAD-81AF-3082DB253DB6Q28180053-B2761AA9-6612-469F-8EB0-B7071EE4B05CQ28216580-74ADAF32-422C-44A4-A460-CE1F4B0F2815Q28480965-9BB17698-8956-49C4-B7E7-716E0B2D573EQ31038583-47645508-FA95-4950-B928-C184E84D3856Q33314914-BF8807D4-2235-4D93-9B6A-4B68213950FDQ33631239-EE8AF7D6-12DC-446B-90C4-3302A25767A2Q34535621-C81E874B-C504-4621-9ADF-711299BED477Q34535740-38954A53-EA93-4FE9-B053-FCE95FB2077EQ34909281-AD559223-7CFD-4F74-A5C4-B7BC3AECA944Q34923735-37414F2E-5606-4C0B-8B5D-20208DCD2D99Q35096589-EAAA883C-6B11-4165-8AD6-0B6F770DD325Q36103191-0E400D88-995B-4EE7-832E-68E735DAF73BQ36444298-4F008904-041A-4F3A-8246-27292A974304Q37072135-87095BDE-9C53-402E-8DE4-48D3131D31D4Q37208016-B2B974B2-2B27-44EF-9C82-8A5CD0529065Q37211663-3E414595-4877-42A4-B50D-0E18243C3FB1Q37297921-5E7C64C8-CF64-49E0-A7D1-599A1E8E66BFQ37514988-549FA318-E102-47D1-8D85-30C15F17E60FQ37750789-72DF57D2-DC50-40FB-AC8A-05E716ACBCBEQ37825834-91677B29-64CD-444C-BAC2-1B217556D66FQ37861625-E593D12B-9E78-4F83-8E96-222B977E201BQ37905799-B641A394-4D52-4D58-88C9-6608BD6FCD49Q38541173-E7CC9B95-5AEA-4F28-B114-FFA90727997BQ38550343-79BA00E9-B3A2-4212-A693-0163AF83A7A0Q38961879-9932C02F-B226-450B-A91D-3DD63DFB051CQ39397461-EAADE723-312F-44FF-9BD7-312EDE208703Q39967664-E47BC845-B8EC-4811-9530-B46A5E92F3C6Q39984972-4E16A284-A117-4078-87D3-F462012D80EBQ40366326-F91435D3-E929-4550-A52C-BEC6D547C473Q40388317-5151AC71-A80A-4604-92CC-53C5376631A4Q40667545-93230035-3BB2-442E-B154-9AB462AE3770
P2860
Telomerase activation by histone deacetylase inhibitor in normal cells.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Telomerase activation by histone deacetylase inhibitor in normal cells.
@ast
Telomerase activation by histone deacetylase inhibitor in normal cells.
@en
type
label
Telomerase activation by histone deacetylase inhibitor in normal cells.
@ast
Telomerase activation by histone deacetylase inhibitor in normal cells.
@en
prefLabel
Telomerase activation by histone deacetylase inhibitor in normal cells.
@ast
Telomerase activation by histone deacetylase inhibitor in normal cells.
@en
P2093
P2860
P356
P1476
Telomerase activation by histone deacetylase inhibitor in normal cells.
@en
P2093
M Takakura
P2860
P304
P356
10.1093/NAR/29.14.3006
P407
P577
2001-07-01T00:00:00Z